trending Market Intelligence /marketintelligence/en/news-insights/trending/5JLtUnwF7Lu2eAwzB6ac4A2 content esgSubNav
In This List

Meridian Bioscience acquires Quebec-based GenePOC

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Meridian Bioscience acquires Quebec-based GenePOC

Cincinnati-based Meridian Bioscience Inc. completed its planned acquisition of GenePOC Inc., a Quebec-based manufacturer of molecular diagnostic instruments and assays.

The company entered into a deal of up to $120 million with GenePOC in late April, with $50 million cash payable at closing and additional future payments of up to $70 million on achieving certain milestones.

Meridian was targeting to complete the transaction by early fourth quarter of 2019.